Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
Context: Head and neck squamous cell carcinomas (HNSCCs) are the sixth most frequent malignancy in the world. Epidermal growth factor receptors (EGFRs) are members of Erb B family of receptors. EGFR is known to act as a driver of tumorigenesis in various carcinomas. Over expression of EGFR in HNSCC...
Main Authors: | Toyaja Jadhav, Ajay Malik, Ahmed Waheed Kashif, Divya Shelly, Prabhashankar S Mishra, Ajay Kumar Baranwal, Rajesh Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2024;volume=67;issue=1;spage=36;epage=45;aulast=Jadhav |
Similar Items
-
<i>EGFR</i> Mutations in Head and Neck Squamous Cell Carcinoma
by: Sindhu Nair, et al.
Published: (2022-03-01) -
Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
by: Bhamini Patel, et al.
Published: (2021-07-01) -
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
by: Guiqin Xie, et al.
Published: (2022-03-01) -
The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
by: Rin Liu, et al.
Published: (2021-12-01) -
Clinical consensus on the treatment of locally advanced squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2023 edition)
by: XU Tingting, HU Chaosu, LI Baosheng
Published: (2023-01-01)